ICD-10 Coding for Plasma Cell Myeloma(C90.0, C90.00, C90.00B)
Explore detailed ICD-10 coding guidelines for plasma cell myeloma, including remission status documentation and common coding pitfalls.
Complete code families applicable to Plasma Cell Myeloma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C90.00 | Multiple myeloma not having achieved remission | Use when the patient has active multiple myeloma without remission. |
|
| C90.01 | Multiple myeloma in remission | Use when the patient is in complete remission from multiple myeloma. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutPlasma Cell Myeloma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Plasma Cell Myeloma.
Failing to specify remission status
Impact
Clinical: May lead to inappropriate treatment decisions., Regulatory: Non-compliance with coding guidelines., Financial: Potential for incorrect billing and reimbursement.
Mitigation
Ensure all documentation includes remission status.
Using unspecified codes for remission status
Impact
Reimbursement: Incorrect coding can lead to reduced reimbursement., Compliance: Non-compliance with coding standards., Data Quality: Impacts the accuracy of clinical data.
Mitigation
Always document and code the specific remission status of the myeloma.
Remission Status Documentation
Impact
Inadequate documentation of remission status can lead to audit issues.
Mitigation
Implement standardized templates for documenting remission status.